VX-814
VX19-814-101
Phase 2 small_molecule terminated
Quick answer
VX-814 for Alpha 1-Antitrypsin Deficiency is a Phase 2 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Alpha 1-Antitrypsin Deficiency
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated